Discover how disrupting growth hormone signaling improves chemotherapy efficacy in mammary cancer treatment through groundbreaking research.
Discover how breast cancer treatment is being personalized for young patients based on hormone receptor status through landmark scientific analysis.
Exploring how a failed prostate cancer trial with mitomycin C and estramustine led to better targeted treatments for hormone-resistant metastatic prostate cancer.
Groundbreaking research shows how high-dose chemotherapy and targeted radiation can achieve unprecedented long-term results for oligometastatic breast cancer patients.
Discover how XRCC1 genetic variations can predict chemotherapy response in breast cancer patients, advancing personalized cancer medicine.